Actigraphy Sensors and Polysomnography Devices Market Size, Share and Growth Outlook, 2026

Actigraphy Sensors and Polysomnography Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Actigraphy Sensors and Polysomnography Devices Market size is forecast to increase from $2.33 Billion in 2026 to $3.66 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034.

The Actigraphy Sensors and Polysomnography Devices market report provides detailed analysis and outlook of Actigraphy Sensors and Polysomnography Devices segments including By Product Type (Actigraphy Sensors, Polysomnography ), By Technology (Wireless Technology, USB Connectivity, GPS-enabled Devices), By Distribution Channel (Hospitals & Sleep Clinics, Diagnostic Laboratories, Homecare Settings, Retail Stores & Pharmacies, Online Sales Channels) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Actigraphy Sensors and Polysomnography (PSG) Devices Industry Overview

Artificial Intelligence and Sleep Diagnostics Modernizing Sleep Medicine

The actigraphy sensors and polysomnography devices industry is evolving rapidly through the integration of artificial intelligence, automated sleep laboratory technologies, advanced wearable sensors, and enhanced diagnostic capabilities. Sleep medicine providers are increasingly adopting digital platforms that improve diagnostic efficiency, expand access to sleep disorder screening, and support continuous patient monitoring outside traditional laboratory environments. The industry is witnessing a convergence between clinical-grade polysomnography systems and wearable actigraphy technologies, enabling more comprehensive assessment of sleep apnea, insomnia, circadian rhythm disorders, and other sleep-related conditions.

Sleep Laboratory Automation Enhancing Diagnostic Efficiency

A major trend across the industry is the automation of sleep study workflows through artificial intelligence-enhanced diagnostic platforms. Healthcare providers are deploying advanced software systems capable of automating data analysis, reducing manual scoring requirements, and improving diagnostic consistency. These technologies are helping sleep laboratories manage growing patient volumes while maintaining clinical accuracy. Automated interpretation tools are increasingly being integrated into polysomnography systems, allowing clinicians to identify sleep abnormalities more efficiently and accelerate treatment decisions. The shift toward intelligent diagnostic infrastructure is improving operational efficiency across sleep centers and hospital-based sleep medicine programs.

Philips Respironics Remediation Supporting Market Stability

The industry continues to address the long-term effects of large-scale respiratory device recalls through comprehensive remediation programs. Philips Respironics reported substantial progress in resolving affected sleep therapy device registrations globally, achieving remediation of 99% of actionable cases. The completion of remediation efforts and closure of the United States patient portal for affected devices represent an important milestone for the sleep therapy sector. These activities have reinforced industry-wide attention toward device quality assurance, patient safety monitoring, regulatory compliance, and lifecycle management for respiratory care equipment utilized in sleep disorder treatment.

Clinical-Grade Wearables Expanding Sleep Monitoring Beyond Traditional Laboratories

Wearable technology is becoming an increasingly important component of sleep diagnostics and long-term monitoring. The adoption of clinical-grade consumer wearables has accelerated significantly, supported by regulatory clearances for sleep apnea detection and irregular sleep pattern monitoring. Technology companies such as Apple and Garmin have introduced software enhancements that enable wearable devices to provide clinically relevant sleep data. Growing consumer adoption of these devices is expanding access to sleep health assessment and facilitating earlier identification of potential sleep disorders. The integration of actigraphy sensors, physiological monitoring capabilities, and advanced analytics is strengthening the role of wearable technologies as complementary tools alongside traditional polysomnography systems. These developments are creating a more connected sleep diagnostics ecosystem that supports both laboratory-based evaluation and continuous real-world monitoring.

Actigraphy Sensors and Polysomnography Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Actigraphy Sensors and Polysomnography Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Koninklijke Philips N.V., ResMed Inc., Natus Medical Incorporated, Garmin Ltd., Nox Medical, Compumedics Limited, SOMNOmedics GmbH, Fitbit, Inc. (Google), Cadwell Industries, Inc., Nihon Kohden Corporation. The Actigraphy Sensors and Polysomnography Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Actigraphy Sensors and Polysomnography Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Actigraphy Sensors and Polysomnography Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Actigraphy Sensors and Polysomnography Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Actigraphy Sensors and Polysomnography Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Actigraphy Sensors and Polysomnography Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Actigraphy Sensors and Polysomnography Devices industry include- Koninklijke Philips N.V., ResMed Inc., Natus Medical Incorporated, Garmin Ltd., Nox Medical, Compumedics Limited, SOMNOmedics GmbH, Fitbit, Inc. (Google), Cadwell Industries, Inc., Nihon Kohden Corporation. The Actigraphy Sensors and Polysomnography Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Actigraphy Sensors and Polysomnography Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Actigraphy Sensors and Polysomnography Devices market remains one of the strongest-performing segments in the country.
The US Actigraphy Sensors and Polysomnography Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Actigraphy Sensors and Polysomnography Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Actigraphy Sensors and Polysomnography Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Actigraphy Sensors and Polysomnography Devices markets

Canada's strong Actigraphy Sensors and Polysomnography Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Actigraphy Sensors and Polysomnography Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Actigraphy Sensors and Polysomnography Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Actigraphy Sensors and Polysomnography Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Actigraphy Sensors and Polysomnography Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Actigraphy Sensors and Polysomnography Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Actigraphy Sensors and Polysomnography Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Actigraphy Sensors and Polysomnography Devices sales through 2034

France Actigraphy Sensors and Polysomnography Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Actigraphy Sensors and Polysomnography Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Actigraphy Sensors and Polysomnography Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Actigraphy Sensors and Polysomnography Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Actigraphy Sensors and Polysomnography Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Actigraphy Sensors and Polysomnography Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Actigraphy Sensors and Polysomnography Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Actigraphy Sensors and Polysomnography Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Actigraphy Sensors and Polysomnography Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Actigraphy Sensors and Polysomnography Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Actigraphy Sensors and Polysomnography Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Actigraphy Sensors and Polysomnography Devices Market Segmentation

By Product Type
Actigraphy Sensors
Polysomnography
By Technology
Wireless Technology
USB Connectivity
GPS-enabled Devices
By Distribution Channel
Hospitals & Sleep Clinics
Diagnostic Laboratories
Homecare Settings
Retail Stores & Pharmacies
Online Sales Channels

Top Companies in Actigraphy Sensors and Polysomnography Devices Industry

Koninklijke Philips N.V.
ResMed Inc.
Natus Medical Incorporated
Garmin Ltd.
Nox Medical
Compumedics Limited
SOMNOmedics GmbH
Fitbit, Inc. (Google)
Cadwell Industries, Inc.
Nihon Kohden Corporation

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025